Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-19
DOI
10.1038/s41598-019-44965-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical use of the polymyxins: the tale of the fox and the cat
- (2018) Eric Wenzler et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Managing Acinetobacter baumannii infections
- (2018) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The new Korean action plan for containment of antimicrobial resistance
- (2017) Sukhyun Ryu Journal of Global Antimicrobial Resistance
- Efficacy and Safety of High Loading Dose of Colistin in Multidrug-Resistant Acinetobacter baumannii: A Prospective Cohort Study
- (2017) Wasan Katip et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients
- (2017) Wasan Katip et al. Infection and Drug Resistance
- Optimizing colistin dosing: Is a loading dose necessary?
- (2016) Lama H. Nazer et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series
- (2016) Ahlem Trifi et al. CHEMOTHERAPY
- Dosing guidance for intravenous colistin in critically-ill patients
- (2016) Roger L Nation et al. CLINICAL INFECTIOUS DISEASES
- The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
- (2016) Yael Dishon Benattar et al. CLINICAL INFECTIOUS DISEASES
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy
- (2016) Ik Sung Choi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dynamic interaction of colistin and meropenem on a WT and a resistant strain ofPseudomonas aeruginosaas quantified in a PK/PD model
- (2016) Ami F. Mohamed et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
- (2015) Gabrielle A. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
- (2015) Roger L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Task force on management and prevention of Acinetobacter baumannii infections in the ICU
- (2015) José Garnacho-Montero et al. INTENSIVE CARE MEDICINE
- Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
- (2015) Ki Hwan Kwon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New pharmacokinetic/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection
- (2015) Soon-Ee Cheah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
- (2015) Roger L Nation et al. LANCET INFECTIOUS DISEASES
- Polymyxin Combinations: Pharmacokinetics and Pharmacodynamics for Rationale Use
- (2015) Phillip J. Bergen et al. PHARMACOTHERAPY
- Colistin: How should It Be Dosed for the Critically Ill?
- (2015) Cornelia Landersdorfer et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale
- (2014) N. Grégoire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- How to treat VAP due to MDR pathogens in ICU patients
- (2014) José Garnacho-Montero et al. BMC INFECTIOUS DISEASES
- A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
- (2014) A. F. Mohamed et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
- (2013) Luisa Sorlí et al. BMC INFECTIOUS DISEASES
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
- (2012) Marilyn N. Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
- (2012) Giulia Vicari et al. CLINICAL INFECTIOUS DISEASES
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
- (2010) Lisa L. Maragakis CRITICAL CARE MEDICINE
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started